Unmet educational needs, challenges, and potential benefits in expanding prescriber bases in oncology and prostate cancer: A scoping review.

e13511 Background: Expanding prescriber bases is essential for more equitable and holistic healthcare, particularly amid the global healthcare workforce crisis. In oncology, healthcare professionals are experiencing increasing workloads due to therapeutic advances and improved patient survival requiring multiple lines of therapy. This scoping review aims to identify benefits and challenges associated with expanding prescriber bases, particularly for oncology and prostate cancer. Methods: A targeted literature review was performed on PubMed to identify relevant articles published between 2019–2024, with additional information sourced from grey literature. Articles were screened against predefined research questions, with data extracted on the benefits, barriers, challenges, and unmet educational needs when expanding a prescriber base. Results: Overall, 51 studies were included. Benefits of expanding prescriber bases included increased professional autonomy, widening skillsets, enhanced job satisfaction, and improved resource allocation. However, a lack of education/training was identified, particularly around guideline adherence, foundational understanding of concepts (e.g., mechanisms of action), and interpretation of efficacy/safety data. Online resources could help reduce reliance on mentors/supervisors and facilitate ongoingeducation and training. In prostate cancer, the growing availability of systemic anticancer therapies (SACT) allows more patients to receive treatment and offers more treatment options for individual patients. Expanding the prescriber base for SACT is required to meet this demand. Several SACT training options were identified including subspecialty accreditation, university accredited courses and online learning modules. Conclusions: Better training programs are critical to ensure healthcare professionals can safely and effectively prescribe treatments, giving patients fair access to the care they need.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e13511
Primary Topic
Economic and Financial Impacts of Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unmet educational needs, challenges, and potential benefits in expanding prescriber bases in oncology and prostate cancer: A scoping review.

Hashim U. Ahmed, Suneel Mundle, Axel S. Merseburger, Taimur T. Shah et al.
Journal of Clinical Oncology
Economic and Financial Impacts of Cancer
article

Unmet educational needs, challenges, and potential benefits in expanding prescriber bases in oncology and prostate cancer: A scoping review.

Hashim U. Ahmed, Suneel Mundle, Axel S. Merseburger, Taimur T. Shah, Bhavini Patel, William Cross, Amit K. Bahl, Alex dos Santos, Declan J. Cahill
article en

Abstract

e13511 Background: Expanding prescriber bases is essential for more equitable and holistic healthcare, particularly amid the global healthcare workforce crisis. In oncology, healthcare professionals are experiencing increasing workloads due to therapeutic advances and improved patient survival requiring multiple lines of therapy. This scoping review aims to identify benefits and challenges associated with expanding prescriber bases, particularly for oncology and prostate cancer. Methods: A targeted literature review was performed on PubMed to identify relevant articles published between 2019–2024, with additional information sourced from grey literature. Articles were screened against predefined research questions, with data extracted on the benefits, barriers, challenges, and unmet educational needs when expanding a prescriber base. Results: Overall, 51 studies were included. Benefits of expanding prescriber bases included increased professional autonomy, widening skillsets, enhanced job satisfaction, and improved resource allocation. However, a lack of education/training was identified, particularly around guideline adherence, foundational understanding of concepts (e.g., mechanisms of action), and interpretation of efficacy/safety data. Online resources could help reduce reliance on mentors/supervisors and facilitate ongoingeducation and training. In prostate cancer, the growing availability of systemic anticancer therapies (SACT) allows more patients to receive treatment and offers more treatment options for individual patients. Expanding the prescriber base for SACT is required to meet this demand. Several SACT training options were identified including subspecialty accreditation, university accredited courses and online learning modules. Conclusions: Better training programs are critical to ensure healthcare professionals can safely and effectively prescribe treatments, giving patients fair access to the care they need.

Journal of Clinical OncologyVol. 43(16_suppl)
Royal Marsden NHS Foundation Trust (GB), Johnson & Johnson (United States) (US), Imperial College Healthcare NHS Trust (GB), Leeds Teaching Hospitals NHS Trust (GB), University Hospitals Bristol NHS Foundation Trust (GB), University Hospital Schleswig-Holstein (DE), Johnson & Johnson (United Kingdom) (GB), University of Lübeck (DE)
Openalex Percentile: Top 83%
Economic and Financial Impacts of Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.